Equity
€291,736 ▲ 10.8%
ASKELA has made a profit without a break since 2020.
ASKELA
Lifetime
13 annual accounts with figures on one time axispeak €86,632 (2012)
€25,341▼ 28.3%
lowest -€90,158 (2019)
€28,346▼ 24.8%
peak €307,596 (2012)
€291,736▲ 10.8%
€1,558▼ 82.1%
peak 0.9 FTE (2013)
-not published
Board3 names since 2019
2 directorsPaul RANSART and 1 other
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Gross margin from €35,331 to €25,341Debts from €8,693 to €1,558Cash from €6,592 to €65,895
Key points
from the 2025 annual accountsFilings
13 annual accounts since 2012
Seven of the last ten came late. The 2015 accounts came latest: 29 days after the end of the period.
Position in the sector
99.5%
Higher solvency than 95% of companies in retail trade. Sector median 33.1% · 22,917 companies.
Checked score
97
Excellent
Financially stronger than 77% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,275 companies (NACE 47, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%
01-2025: 0.7%▲ +0.3 percentage points vs 12-2024
02-2025: 1.0%▲ +0.3 percentage points vs 01-2025
03-2025: 1.2%▲ +0.2 percentage points vs 02-2025
04-2025: 1.9%▲ +0.7 percentage points vs 03-2025
05-2025: 2.0%▲ +0.1 percentage points vs 04-2025
06-2025: 2.6%▲ +0.6 percentage points vs 05-2025
07-2025: 3.9%▲ +1.3 percentage points vs 06-2025highest value
08-2025: 3.9%● unchanged vs 07-2025highest value
09-2025: 0.2%▼ -3.7 percentage points vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.3%▲ +0.1 percentage points vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: < 0.1%▼ -0.3 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Sector: Retail trade (NACE 47)
lowers risk
Liquidity: current ratio 123.30, cash €65,895
Equity €291,736 (99.5% of total assets)
Founded in 2011
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 83% on liquidity, 73% on profitability and 62% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as ASKELA has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of ASKELA itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for ASKELA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €25,000 on 30-day terms is acceptable
Short-term debt is 0.5% and cash 22.5% of total assets. 0.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 days early
2024
26 days late
2023
on the day
2022
on the day
2020
9 days late
2019
18 days late
2018
13 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 8 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0835952928
Company renamed from HP PHARMA to ASKELA
Changes of role: Paul RANSART (director) and PHARMACOACH (director) · Permanent representative: Stéphanie THOMAES · “1) l'exploitation d'officines pharmaceutiques dans le respect des règles édictées par l'Ordre des…” (deed in French) · General meeting of 10-07-2023 · Gazette deed
Registered office moved from Honnelles to Chièvres
New registered office: Rue de l'Eglise, 48 7950 Chièvres (Huissignies) · Previous registered office: Rue Bourdon, 21 7387 Honnelles (Roisin) · Resignation: Christine Bataille (manager) · General meeting of 16-05-2019 · Gazette deed
First establishment
HP Pharma, Rue Bourdon 21, Honnelles
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ASKELA Chièvres | €293,294 | €25,341 | 99.5% | - |
| TANNHAUSER PHARAESCOS Koekelberg | €292,153 | €30,406 | 46.9% | 0 |
| AP'ART Ghent | €322,780 | €30,457 | 55.8% | - |
| Apotheek Jacobs Lokeren | €307,849 | €33,846 | 90.8% | - |
| Almax Pharma Walcourt | €346,656 | €29,811 | 87.5% | - |
| PHARMACIE de SYLVA Jette | €305,589 | €33,864 | 56.1% | - |
| Sapos Aalst | €241,792 | €29,984 | 69.5% | - |
These companies have the same main activity as ASKELA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €242,000 and €347,000, founded between 2007 and 2014.
Official details
Source: KBO- Status
- Active since 27-04-2011Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.198.771.1557387 Honnelles, since 01-05-2011
- Financial year end
- 31 December
- Peppol
- Reachable since 26-01-2026
Annual accounts 2025
- ≈ €120,000estimated
- €293,294▲ 7.8%
- Filing
- Filed on 23-07-2026, 8 days before the end of the filing period
Insights on ASKELA
ASKELA files the micro format. That format states no turnover. The gross margin fell from €86,632 in 2012 to €25,341 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ASKELA
- What is the company number of ASKELA?
- The company number of ASKELA is 0835.952.928. The VAT number is the same number with BE in front: BE 0835.952.928.
- Where is ASKELA based?
- The registered office is at Rue de l'Eglise 48, 7950 Chièvres.Company details
- What does ASKELA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of ASKELA?
- ASKELA is a private limited company (BV).
- When was ASKELA founded?
- ASKELA was founded on 27-04-2011.
- Is ASKELA still active?
- Yes, ASKELA is an active enterprise in the KBO register.
- What is the turnover of ASKELA?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €25,341 and 51 comparable companies (NACE 477). It probably lies between €66,000 and €220,000.Financials
- Is ASKELA profitable?
- In financial year 2025, ASKELA made a profit of €28,346.
- Where can I find the annual accounts of ASKELA?
- ASKELA filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ASKELA due?
- ASKELA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.